Tissue-factor-pathway-Inhibitor: Biochemie, Molekularbiologie, Physiologie und Pathophysiologie

• Literatur

• 1 Bajaj MS, Bajaj SP. Tissue factor pathway inhibitor: potential therapeutic applications. Thromb Haemost 1997; 78: 471-7.
• 2 Broze jr GJ, Miletich JP. Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells. Proc Natl Acad Sci, USA 1987; 84: 1886-90.
• 3 Broze GJ, Warren LA, Novotny WF. et al. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood 1988; 71: 335-43.
• 4 Broze jr GJ, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitztype inhibitor. Biochemistry 1990; 29: 7539-46.
• 5 Broze jr GJ. Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood Coagul Fibrinol 1995; 6 (Suppl. 01) 1-13.
• 6 Broze jr GJ. Tissue factor pathway inhibitor. Hämostaseologie 1997; 1: 73-7.
• 7 Girard TJ, Warren LA, Novotny WF. et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 1989; 338: 518-20.
• 8 Girard TJ, Eddy R, Wesselschmidt RL. et al. Structure of the human lipoprotein-associated coagulation inhibitor gene. Intron/exon gene organization and localization of the gene to chromosome 2. J Biol Chem 1991; 266: 5036-41.
• 9 Higuchi DA, Wun TC, Likert KM. et al. The effect of leukocyte elastase on tissue factor pathway inhibitor. Blood 1992; 79: 1712-9.
• 10 Hjort PF. Intermediate reactions in the coagulation of blood with tissue thromboplastin. Scan J Clin Lab Invest 1957; 9 (Suppl. 27) 1-173.
• 11 Novotny WF, Girard TJ, Miletich JP. et al. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood 1988; 72: 2020-5.
• 12 Novotny WF, Day K, Wun TC. et al. Platelet LACI is present in novel granules. Blood 1990; 76 (Suppl. 01) 469.
• 13 Pedersen AH, Nordfang O, Norris F. et al. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor initiated coagulation reactions. J Biol Chem 1990; 265: 16786-93.
• 14 Rapaport SI. The extrinsic pathway inhibitor: a regulator of tissue factor dependent blood coagulation. Thromb Haemost 1991; 66: 6-15.
• 15 Sandset PM, Abildgaard U. Extrinsic pathway inhihitor - the key to feedback control of blood coagulation initiated by tissue thromboplastin. Haemostasis 1991; 21: 219-39.
• 16 Sandset PM, Bendz B. Tissue factor pathway inhibitor: clinical deficiency states. Thromb Haemost 1997; 78: 467-70.
• 17 Sandset PM, Abildgaard U, Pettersen M. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions. Thromb Res 1987; 47: 389-400.
• 18 Sandset PM, Abildgaard U, Larsen ML. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res 1988; 50: 803-13.
• 19 Warn-Cramer BJ, Maki SL, Zivelin A. et al. Partial purification and characterization of extrinsic pathway inhibitor (the factor Xadependent plasma inhibitor of factor VIIa/ tissue factor). Thromb Res 1987; 48: 11-22.
• 20 Warn-Cramer BJ, Rao LVM, Maki SL. et al. Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition. Thromb Haemost 1988; 60: 453-6.
• 21 Warr TA, Rao LVM, Rapaport SI. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of antitissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 1990; 75: 1481-9.